These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23642278)
1. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. Mao L; Yang C; Wang J; Li W; Wen R; Chen J; Zheng J J Transl Med; 2013 May; 11():111. PubMed ID: 23642278 [TBL] [Abstract][Full Text] [Related]
2. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition. Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245 [TBL] [Abstract][Full Text] [Related]
4. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation. Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419 [TBL] [Abstract][Full Text] [Related]
5. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis. Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613 [TBL] [Abstract][Full Text] [Related]
6. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. Fang XF; Hou ZB; Dai XZ; Chen C; Ge J; Shen H; Li XF; Yu LK; Yuan Y World J Gastroenterol; 2013 Apr; 19(15):2331-9. PubMed ID: 23613626 [TBL] [Abstract][Full Text] [Related]
7. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9. Zhou D; Ye C; Pan Z; Deng Y Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772 [No Abstract] [Full Text] [Related]
8. Expression of SATB1 promotes the growth and metastasis of colorectal cancer. Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456 [TBL] [Abstract][Full Text] [Related]
9. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression. Shen Z; Zeng Y; Guo J; Wu Y; Jiang X; Ding R; Wu C; Li R; Luo B; Zeng C; Jiang H; Jie W J Transl Med; 2013 Sep; 11():217. PubMed ID: 24047082 [TBL] [Abstract][Full Text] [Related]
10. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma. Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145 [TBL] [Abstract][Full Text] [Related]
11. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer. Sun L; Liu L; Yang J; Li H; Zhang C J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma. Cheng C; Wan F; Liu L; Zeng F; Xing S; Wu X; Chen X; Zhu Z PLoS One; 2014; 9(5):e97406. PubMed ID: 24835085 [TBL] [Abstract][Full Text] [Related]
13. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389 [TBL] [Abstract][Full Text] [Related]
14. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion. Aktary Z; Pasdar M PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116 [TBL] [Abstract][Full Text] [Related]
15. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer. Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study. Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096 [TBL] [Abstract][Full Text] [Related]
17. Expression and biological roles of SATB1 in human bladder cancer. Han B; Luan L; Xu Z; Wu B Tumour Biol; 2013 Oct; 34(5):2943-9. PubMed ID: 23696028 [TBL] [Abstract][Full Text] [Related]
18. miR-449a regulates biological functions of hepatocellular carcinoma cells by targeting SATB1. Li J; Zheng Z; Zhang J; Tang Y; Wan X J BUON; 2020; 25(3):1375-1382. PubMed ID: 32862579 [TBL] [Abstract][Full Text] [Related]
19. Chromatin organizer SATB1 as a novel molecular target for cancer therapy. Mir R; Pradhan SJ; Galande S Curr Drug Targets; 2012 Dec; 13(13):1603-15. PubMed ID: 22998183 [TBL] [Abstract][Full Text] [Related]
20. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma. Frömberg A; Rabe M; Aigner A Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]